Journal
EMERGING INFECTIOUS DISEASES
Volume 8, Issue 5, Pages 522-524Publisher
CENTERS DISEASE CONTROL & PREVENTION
DOI: 10.3201/eid0805.010346
Keywords
-
Categories
Ask authors/readers for more resources
To guide selection of carbapenems or fourth-generation cephalosporins as therapy, 110 Klebsiella pneumoniae isolates with extended-spectrum beta-lactamases from Taiwan were characterized by phenotypic (MICs), molecular, and chemical methods. MIC patterns of ceftazidime and cefepime clearly differentiate strains treatable by cefepime and those capable of efficiently hydrolyzing available cephalosporins (CTX-M series and SHV-types). Continued use of cefepime appears to be a treatment option in cases for which MIC results are available and interpreted by the criteria presented.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available